TSC2 and tuberous sclerosis: Indeed, recent studies indicate that at least 50% of TSC cases who fulfill the clinical diagnostic criteria and do not have a mutation identified by standard molecular testing will have a pathogenic TSC1 or TSC2 variant in mosaic form12,13.